Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
02:00am, Monday, 18'th Mar 2024
Iovance Biotherapeutics just got a cell therapy for melanoma approved. The medicine will likely be very costly to make and deliver to patients.
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
09:00am, Sunday, 17'th Mar 2024
Investors need not be concerned about the FDA's approval delay for Eli Lilly's Alzheimer's drug. Novo Nordisk recently picked up a regulatory win that makes the stock even more attractive.
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
03:24am, Sunday, 17'th Mar 2024
Sales of new highly effective weight management treatments are soaring. Eli Lilly entered the weight management arena after its main rival, Novo Nordisk, but clinical trial results suggest its drug co
The Trillion-Dollar Crystal Ball: 3 Companies Next in Line for the Market Milestone
02:00pm, Saturday, 16'th Mar 2024
There are only six trillion-dollar stocks worldwide, every one of which is a popular name. And they all rightfully sit at the top of their sectors.
Eli Lilly Just Had a Setback. Is Its Stock Still a Buy?
09:15am, Saturday, 16'th Mar 2024
Eli Lilly is facing a major delay with its latest Alzheimer's program. Regulators are bringing in outside experts to review its approval request.
Eli Lilly Partners With Amazon's Pharmacy Business: Here's Why Both Stocks Should Win From the Deal
05:50am, Saturday, 16'th Mar 2024
Eli Lilly recently selected Amazon Pharmacy to fill online prescriptions for its LillyDirect platform. This partnership benefits both Lilly and Amazon.
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
01:46pm, Friday, 15'th Mar 2024
Eli Lilly's powerful weight-loss drug Zepbound hit 77,590 new prescriptions in the U.S. for the week ending March 8, surpassing Novo Nordisk's rival obesity medicine Wegovy for the first time since it
Call of the Day: Eli Lilly
01:16pm, Friday, 15'th Mar 2024
JP Morgan is hiking Eli Lilly's price target to $850. The Investment Committee debate it.
Can Eli Lilly Stock Double in 5 Years? Here's What It Would Take.
09:15am, Friday, 15'th Mar 2024
Eli Lilly has a huge opportunity in the anti-obesity market to generate tens of billions in revenue. The big battle could be over which company develops the best weight-loss drug.
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
08:15am, Friday, 15'th Mar 2024
When many investors hear the word mania, they may think of artificial intelligence (AI) stocks or Bitcoin. Both investments have yielded market-beating returns and have room to run higher.
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
05:50am, Friday, 15'th Mar 2024
Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.
Lilly (LLY) Partners Amazon to Deliver Drugs Like Zepbound
10:56am, Thursday, 14'th Mar 2024
Eli Lilly (LLY) partners with Amazon Pharmacy to help deliver its obesity, migraine and diabetes drugs, including Zepbound.
7 Growth Stocks to Sell in March Before They Crash & Burn
10:23am, Thursday, 14'th Mar 2024
If you want to know which growth stocks to sell this month, you're in the right place. Growth stocks have had a tremendous start to 2024.
Should Investors Worry About Eli Lilly's Latest Regulatory Setback?
08:30am, Thursday, 14'th Mar 2024
Eli Lilly's potential approval for an Alzheimer's disease therapy is being delayed again. But even if the company doesn't earn this approval, it won't be the end of the world.
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
06:51pm, Wednesday, 13'th Mar 2024
Eli Lilly (LLY) reachead $757.84 at the closing of the latest trading day, reflecting a +0.38% change compared to its last close.
